Royalty Pharma to Present at TD Cowen’s 45th Annual Health Care Conference
Royalty Pharma plc (Nasdaq: RPRX) today announced that it will participate in a fireside chat at TD Cowen’s 45 th Annual Health Care Conference on March 4, 2025 at 2:30 p.m. ET. The webcast will be accessible from Royalty Pharma’s “Events” page at The webcast will also be archived for a minimum of thirty days.
2hon MSN
Mechanics Agree These Are the 2 Most Reliable Cars You Can Buy ...
TD Cowen analyst Lance Vitanza raised the firm’s price target on TKO Group (TKO) to $200 from $145 and keeps a Buy rating on the shares. The ...
NetApp (NASDAQ:NTAP – Free Report) had its price target cut by TD Cowen from $160.00 to $130.00 in a research report released ...
Microsoft Corp. has canceled some leases for US data center capacity, according to TD Cowen, raising broader concerns over ...
The webcast may also be accessed through Spero Therapeutics’ website (www.sperotherapeutics.com) on the “Events and Presentations” page under the “Connect” tab. A replay will be ...
Bloom Energy (NYSE:BE – Free Report) had its price target lifted by TD Cowen from $13.00 to $20.00 in a report released on Friday morning, MarketBeat.com reports. TD Cowen currently has a hold rating ...
TD Cowen initiated coverage of Disc Medicine (IRON) with a Buy rating and no price target The shares are pricing in an opportunity for ...
Mit Blick auf den KI-Nachfrage-Ausblick lässt ein Bericht der Investmentbank TD Cowen aufhorchen: Microsoft hat demnach ...
Microsoft Corp. has canceled some leases for US data center capacity, according to TD Cowen, raising broader concerns over ...
In a report released yesterday, Ritu Baral from TD Cowen maintained a Buy rating on Milestone Pharmaceuticals (MIST – Research Report), with a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback